Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care.
Vincenza ConteducaPiergiorgio Di TullioRossana AllampreseGiuseppina BrunoCristian LolliGiuseppe SchepisiAldo RosanoGuido GiordanoMarianna GarofoliVincenzo Emanuele ChiuriLucia FratinoElisa ZanardiLuca GalliFrancesco MassariUgo Giovanni FalagarioPasquale RescignoGiuseppe FornariniFrancesca SanguedolceDaniele SantiniGiuseppe ProcopioOrazio CaffoGiuseppe CarrieriMatteo LandriscinaUgo De GiorgiPublished in: Prostate cancer and prostatic diseases (2024)
Our study showed that duration on ADT for mHSPC was significantly associated with survival in mCRPC undergoing ARSI. These findings suggest a possible connection between initial management of prostate tumour and a better prognostication in mCRPC. Prospective trials are warranted.